Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Oct;20(5):557-61.
doi: 10.1007/BF01061471.

Sample size determination for bioequivalence assessment using a multiplicative model

Affiliations

Sample size determination for bioequivalence assessment using a multiplicative model

D Hauschke et al. J Pharmacokinet Biopharm. 1992 Oct.

Abstract

In bioequivalence studies Cmax and AUC serve as the primary pharmacokinetic characteristics of rate and extent of absorption. Based on pharmacokinetic relationships and on empirical evidence, the distribution of these characteristics corresponds to a multiplicative model, which implies a logarithmic normal distribution in the case of a parametric analysis. Hence, consideration is given to exact and approximate formulas of sample sizes in the case of a multiplicative model.

PubMed Disclaimer

References

    1. Int J Clin Pharmacol Ther Toxicol. 1991 Jan;29(1):1-8 - PubMed
    1. Clin Pharmacokinet. 1992 Apr;22(4):247-53 - PubMed
    1. Int J Clin Pharmacol Ther Toxicol. 1992 May;30(5):181-7 - PubMed
    1. Stat Med. 1992 May;11(7):881-96 - PubMed
    1. J Pharmacokinet Biopharm. 1990 Apr;18(2):137-44 - PubMed